Cargando…

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction

AIMS: Not all patients with heart failure with reduced ejection fraction (HFrEF) benefit equally from beta‐blockers. Previous studies suggest that myocardial strain that reflects myocardial deformation may have a better prognostic value than the left ventricular ejection fraction. We aimed to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Chan Soon, Park, Jin Joo, Hwang, In‐Chang, Park, Jun‐Bean, Park, Jae‐Hyeong, Cho, Goo‐Yeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934950/ https://www.ncbi.nlm.nih.gov/pubmed/35001562 http://dx.doi.org/10.1002/ehf2.13800

Ejemplares similares

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes
por: Park, Jin Joo, et al.
Publicado: (2020)

Determinants of the survival benefit associated with statins in patients with acute heart failure
por: Park, Chan Soon, et al.
Publicado: (2021)

Left Atrial Strain to Predict Stroke in Patients With Acute Heart Failure and Sinus Rhythm
por: Park, Jae‐Hyeong, et al.
Publicado: (2021)

Prognostic Value of Biventricular Strain in Risk Stratifying in Patients With Acute Heart Failure
por: Park, Jae‐Hyeong, et al.
Publicado: (2018)

Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction
por: Cha, Myung-Jin, et al.
Publicado: (2017)

Impact of sex and myocardial function on association of obesity with mortality in Asian patients with acute heart failure: a retrospective analysis from the STRATS-AHF registry
por: Park, Chan Soon, et al.
Publicado: (2020)

Correction: Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction
por: Cha, Myung-Jin, et al.
Publicado: (2017)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
por: Moon, Mi‐Gil, et al.
Publicado: (2021)

Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018)

Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients
por: Kwon, Hee-Jin, et al.
Publicado: (2019)

Prognostic Implications of Mechanical Phenotypes in Heart Failure Characterized by 3‐Chamber Strain Echocardiography
por: Park, Jiesuck, et al.
Publicado: (2022)

Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure
por: Kwak, Soongu, et al.
Publicado: (2021)

Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
por: Liu, Feng, et al.
Publicado: (2014)

Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction
por: Luzum, Jasmine A., et al.
Publicado: (2023)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction
por: Xu, Xizhen, et al.
Publicado: (2019)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019)

Feasibility of the contraction–relaxation coupling index in outcome prediction for patients with acute heart failure
por: Park, Jiesuck, et al.
Publicado: (2022)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction
por: Park, Chan Soon, et al.
Publicado: (2019)

Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
por: Waranugraha, Yoga, et al.
Publicado: (2021)

Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction
por: Joo, Seung-Jae, et al.
Publicado: (2022)

Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction
por: Kim, Hyue Mee, et al.
Publicado: (2021)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients
por: Oh, Ji‐Hye, et al.
Publicado: (2022)

Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2023)

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
por: Schurtz, Guillaume, et al.
Publicado: (2023)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
por: Choi, Ki Hong, et al.
Publicado: (2019)

The effect of exercise training on biventricular myocardial strain in heart failure with preserved ejection fraction
por: Angadi, Siddhartha S., et al.
Publicado: (2017)

Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
por: Turgeon, Ricky D., et al.
Publicado: (2019)

Comparison of global and regional myocardial strains in patients with heart failure with a preserved ejection fraction vs hypertension vs age-matched control
por: Kim, Hyung Yoon, et al.
Publicado: (2020)

Beta Blockers Up-Titration in Patients with Heart Failure Reduced Ejection Fraction and Cardiac Resynchronization Therapy, a Single Center Study
por: Masarone, Daniele, et al.
Publicado: (2019)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Time-Dependent Regional Myocardial Strains in Patients with Heart Failure with a Preserved Ejection Fraction
por: Smith, Shane P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_853p9kqi5eq43jgr17r7crl2rn